Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Axsome Therapeutics AXSM Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-278,835	Closed	-$50.9M	–	52
2025 Q4	$50.9M	Sell	278,835 -47,483	-15%	-$6.63M	4.52%	6
2025 Q3	$39.6M	Hold	326,318	–	–	3.06%	15
2025 Q2	$34.1M	Buy	326,318 +40,824	+14%	+$4.32M	4.03%	11
2025 Q1	$33.3M	Buy	285,494 +251,775	+747%	+$28.7M	6.87%	3
2024 Q4	$2.85M	Buy	+33,719	New	+$3.1M	0.35%	45

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's AXSM Position: Q1 2026 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 278,835 shares — an estimated $50.9M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in AXSM in Q4 2024 and held it in 5 quarters. The position peaked at $50.9M in Q4 2025. 410 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 278,835 Axsome Therapeutics shares in Q1 2026, an estimated $50.9M.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Axsome Therapeutics in Q4 2024 and held it in 5 quarters.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Axsome Therapeutics position peaked at $50.9M in Q4 2025.
410 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q1 2026, filed 12 May 2026.